The effects of BH4 treatment in the development of the cardiac hypertrophy and fibrosis by chronic pressure overload in rats

被引：0
|
作者：
Kumagai, Sumito [1 ]
Ishibashi, Masaaki [1 ]
Hiroi, Toshihitc [1 ]
Wajima, Teruaki [1 ]
Ishii, Masakazu [1 ]
Kiuchi, Yuji [1 ]
Shimizu, Shunichi [1 ]
机构：
[1] Showa Univ, Sch Pharm Sci, Dept Pathophysiol, Shinagawa Ku, Tokyo 1428555, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：266P / 266P
页数：1
相关论文
共 50 条
  • [31] GROWTH HORMONE ATTENUATES MYOCARDIAL FIBROSIS IN RATS WITH CHRONIC PRESSURE OVERLOAD-INDUCED LEFT VENTRICULAR HYPERTROPHY
    Moreira, Vanessa O.
    Pereira, Camila A.
    Silva, Mirella O.
    Felisbino, Sergio L.
    Cicogna, Antonio C.
    Okoshi, Katashi
    Aragon, Flavio F.
    Padovani, Carlos R.
    Okoshi, Marina P.
    Castro, Ana V. B.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (03): : 325 - 330
  • [32] Effects of indapamide in rats with pressure overload left ventricular hypertrophy
    Böcker, W
    Hupf, H
    Grimm, D
    Kurzidim, K
    Schunkert, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (04) : 481 - 486
  • [33] Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy
    Palladini, G
    Ferrero, I
    Fallarini, S
    Tozzi, R
    Nano, R
    Facoetti, A
    Busca, G
    Fogari, R
    Ferrari, AU
    Perlini, S
    JOURNAL OF HYPERTENSION, 2003, 21 : S36 - S36
  • [34] Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy
    Kompa, Andrew R.
    Wang, Bing H.
    Phrommintikul, Arintaya
    Ho, Pei Y.
    Kelly, Darren J.
    Behm, David J.
    Douglas, Stephen A.
    Krum, Henry
    PEPTIDES, 2010, 31 (08) : 1523 - 1530
  • [35] Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan
    Turcani, M
    Rupp, H
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 188 (1-2) : 225 - 233
  • [36] Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan
    Marian Turcani
    Heinz Rupp
    Molecular and Cellular Biochemistry, 1998, 188 : 225 - 233
  • [37] Effects of low-dose spironolactone combined with irbesartan on cardiac hypertrophy induced by pressure overload in rats
    Ma, Jingtao
    Zhang, Hongxue
    Guo, Huicai
    Xu, Yanfang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2014, 6 (06): : 809 - 819
  • [38] Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats
    Chu, Li
    Li, Pinya
    Song, Tao
    Han, Xue
    Zhang, Xuan
    Song, Qiongtao
    Liu, Tao
    Zhang, Yuanyuan
    Zhang, Jianping
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (09) : 1191 - 1207
  • [39] Insulin treatment prevents an endothelial deficiency of tetrahydrobiopterin (BH4) in diabetic rats
    Meininger, CJ
    Haynes, T
    Kelly, KA
    Bridenbaugh, E
    Yan, WN
    Hatakeyama, K
    Wu, GY
    FASEB JOURNAL, 2002, 16 (04): : A514 - A514
  • [40] Cardiac apoptosis in the transition from left ventricular hypertrophy to left ventricular dysfunction in rats with chronic pressure overload
    Morisco, C
    Monti, F
    Condorelli, G
    Notte, A
    deRienzo, A
    Lembo, G
    Trimarco, B
    CIRCULATION, 1997, 96 (08) : 4177 - 4177
12345